Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine
Reference132 articles.
1. Curtin F, Schulz P. Assessing the benefit: risk ratio of a drug–randomized and naturalistic evidence. Dialogues Clin Neurosci. 2011;13:183–90.
2. Ferrari A, Baraldi C, Licata M, Rustichelli C. Polypharmacy Among Headache Patients: A Cross-Sectional Study. CNS Drugs. 2018;32:567–78.
3. Pomes LM, Guglielmetti M, Bertamino E, Simmaco M, Borro M, Martelletti P. Optimising migraine treatment: from drug-drug interactions to personalized medicine. J Headache Pain. 2019;20:56.
4. •• Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55:3–20. AHS guidelines for an acute treatment of migraine.
5. •• American Headache Society. The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice. Headache. 2019;59:1–18. Position statement with recommendations for acute and preventive treatment, including novel drugs.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献